Gault Cheryl
Chief Operating Officer · 11 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | RAPP | Rapport Therapeutics, Inc. | Sale | 3,792 | $41.39 | $156,963.77 | filing |
| 2026-06-30 | RAPP | Rapport Therapeutics, Inc. | Sale | 3,308 | $42.17 | $139,505.64 | filing |
| 2026-06-30 | RAPP | Rapport Therapeutics, Inc. | Sale | 1,900 | $40.09 | $76,173.66 | filing |
| 2026-06-30 | RAPP | Rapport Therapeutics, Inc. | Sale | 1,000 | $43.15 | $43,154.70 | filing |
| 2026-03-30 | RAPP | Rapport Therapeutics, Inc. | Sale | 7,161 | $28.04 | $200,795.16 | filing |
| 2026-03-30 | RAPP | Rapport Therapeutics, Inc. | Sale | 2,839 | $28.55 | $81,061.97 | filing |
| 2026-03-05 | RAPP | Rapport Therapeutics, Inc. | Sale | 2,014 | $28.93 | $58,265.02 | filing |
| 2025-11-26 | RAPP | Rapport Therapeutics, Inc. | Sale | 5,000 | $30.10 | $150,486.50 | filing |
| 2025-11-26 | RAPP | Rapport Therapeutics, Inc. | Option exercise | 5,000 | $1.80 | $9,000.00 | filing |
| 2025-09-08 | RAPP | Rapport Therapeutics, Inc. | Sale | 5,000 | $38.33 | $191,650.00 | filing |
| 2025-09-08 | RAPP | Rapport Therapeutics, Inc. | Option exercise | 5,000 | $1.80 | $9,000.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.